Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women Aimee Seungdamrong, M.D., Anne Z. Steiner, M.D., M.P.H., Clarisa R. Gracia, M.D., M.S.C.E., Richard S. Legro, M.D., Michael P. Diamond, M.D., Christos Coutifaris, M.D., Ph.D., William D. Schlaff, M.D., Peter Casson, M.D., Gregory M. Christman, M.D., Randal D. Robinson, M.D., Hao Huang, M.D., M.P.H., Ruben Alvero, M.D., Karl R. Hansen, M.D., Ph.D., Susan Jin, M.P.H., Esther Eisenberg, M.D., M.P.H., Heping Zhang, Ph.D., Nanette Santoro, M.D. Fertility and Sterility Volume 108, Issue 5, Pages 843-850 (November 2017) DOI: 10.1016/j.fertnstert.2017.08.026 Copyright © 2017 Terms and Conditions
Figure 1 1. The association between pregnancy outcomes and (A) thyroid-stimulating hormone (TSH) level or (B) the presence of anti-thyroid peroxidase (TPO) antibodies. Fertility and Sterility 2017 108, 843-850DOI: (10.1016/j.fertnstert.2017.08.026) Copyright © 2017 Terms and Conditions